comparemela.com

Latest Breaking News On - Christian ottmann - Page 1 : comparemela.com

TU Eindhoven biotech start-up Ambagon Therapeutics raises €75M

The biotechnology start-up Ambagon Therapeutics has raised 75 million euros (85 million dollars) in a financing round. With the money, the Dutch-American company will develop medicines that can be used to better treat cancer in the future. Ambagon was founded in 2020 on the basis of a number of years of research at TU Eindhoven by Eline Sijbesma, Loes Stevers and others.

Ambagon adds $85M for molecular glues that stick to elusive protein targets

Biotech startup Ambagon Therapeutics is taking a new approach to making elusive protein targets “druggable” by using molecular glues. The biotech has a pipeline of preclinical cancer drugs and it has raised $85 million to support their development.

Ambagon Therapeutics Raises $85M in Series A Funding

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.